Chloroquine nasal drops in asymptomatic & mild COVID-19: An exploratory randomized clinical trial
Randomized Controlled Trial
[키워드] 1:1
Administered
administration
adverse event
Analysis
analyzed
ARMS
Asymptomatic
asymptomatic patient
Chloroquine - COVID-19
clinical
Control
COVID-19
COVID-19 infection
cycle threshold
demonstrated
Efficacy and safety
enrolment
exploratory
eye drop
False-positive
greater
indicated
Infection
intervention arm
Local
measure
Mild
mild COVID-19 illness
modified intention-to-treat
nasal
nasal drop
nasal drops
National Early Warning Score
outcome
Patient
patients
prevention of COVID-19
progression
Prophylaxis
proportion
randomization
Randomized
randomized clinical trial
receiving
reducing
RT-PCR
Sample size
SARS CoV-2
score
Seven
significant difference
standard treatment
Supportive treatment
tissue
Treatment
Trial
uninfected
Viral load
Virological
was done
were excluded
were measured
[DOI] 10.4103/ijmr.IJMR_3665_20 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.4103/ijmr.IJMR_3665_20 PMC 바로가기 [Article Type] Randomized Controlled Trial